SBCF involved in Implementation PhD Programme

December 8, 2020


SBCF will collaborate with biopharmaceutical company from Wrocław, Captor Therapeutics within the scheme of the Implementation PhD programme. One of the selected PhD students is Kamil Przytulski, who recently joined Glatt Lab and is expected to actively use our cryoEM and MX services

Kamil Przytulski joined Glatt Lab as a PhD student within the Implementation PhD programme in collaboration with biopharmaceutical company from Wrocław, Captor Therapeutics. During his PhD Programme he will be a frequent user of our facility to conduct his research.

The aim of this Implementation PhD Programme is to establish proper conditions for building a stronger relationship between scientific community and the socio-economic environment in our country. This will simplify the commercialization of scientific research and help train well-skilled employees like Kamil, who do not want to give up their career while pursuing a scientific degree. In his work he will focus on structural characterization of Targeted Protein Degradation systems in order to optimize chemotype of potential ligands.
You can read more about Kamil and his future project HERE

kamil przytulski
Kamil Przytulski